Home » Topics » BioWorld Science

BioWorld Science
RSS

Regeneron ADC REGN3124-PBD prolongs survival in mice with intracranial glioblastoma tumors

Oct. 22, 2021

Splice variant in DEGS1 leads to hypomyelinating leukodystrophy-like phenotype

Oct. 22, 2021

Atreca and Gates MRI enter licensing agreement on MAM-01 for malaria

Oct. 22, 2021

Ligand grants CRDC Asian rights to develop COVID-19 antiviral using BEPro technology

Oct. 22, 2021

Cedilla announces lead programs focused on conditional inhibition of TEAD and CDK2

Oct. 22, 2021

Purnovate selects PNV-5030 as lead compound in pain program

Oct. 22, 2021

SLFN11 predicts treatment response to TAS-1553 in AML

Oct. 22, 2021

Loxo Oncology details discovery and testing of PI3Kalpha and FGFR inhibitors

Oct. 22, 2021

GLI1 inhibition as a novel strategy for the treatment of uterine leiomyosarcoma

Oct. 22, 2021

Researchers identify new GPR52 agonists

Oct. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...